Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19

Background. Health and economies are both affected by the coronavirus disease-19 (COVID-19) global pandemic. Angiotensin-converting enzyme 2 (ACE2) is a polymorphic enzyme that is a part of the renin-angiotensin system, and it plays a crucial role in viral entry. Previous investigations and studies...

Full description

Saved in:
Bibliographic Details
Main Authors: Taravat Talebi, Tannaz Masoumi, Katayoun Heshmatzad, Mahshid Hesami, Majid Maleki, Samira Kalayinia
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Genetics Research
Online Access:http://dx.doi.org/10.1155/2023/2593199
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546668804833280
author Taravat Talebi
Tannaz Masoumi
Katayoun Heshmatzad
Mahshid Hesami
Majid Maleki
Samira Kalayinia
author_facet Taravat Talebi
Tannaz Masoumi
Katayoun Heshmatzad
Mahshid Hesami
Majid Maleki
Samira Kalayinia
author_sort Taravat Talebi
collection DOAJ
description Background. Health and economies are both affected by the coronavirus disease-19 (COVID-19) global pandemic. Angiotensin-converting enzyme 2 (ACE2) is a polymorphic enzyme that is a part of the renin-angiotensin system, and it plays a crucial role in viral entry. Previous investigations and studies revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ACE2 have a considerable association. Recently, ACE2 variants have been described in human populations in association with cardiovascular and pulmonary conditions. In this study, genetic susceptibility to COVID-19 in different populations was investigated. Methods and Results. We evaluated the identified variants based on the predictive performance of 5 deleteriousness-scoring methods and the 2015 American College of Medical Genetics and Genomics (ACMG) guidelines. The results indicated 299 variants within the ACE2 gene. The variants were analyzed by different in-silico analysis tools to assess their functional effects. Ultimately, 5 more deleterious variants were found in the ACE2 gene. Conclusions. Collecting more information about the variations in binding affinity between SARS-CoV-2 and host-cell receptors due to ACE2 variants leads to progress in treatment strategies for COVID-19. The evidence accumulated in this study showed that ACE2 variants in different populations may be associated with the genetic susceptibility, symptoms, and outcome of SARS-CoV-2 infection.
format Article
id doaj-art-7411e6cf8cc14739a79f04e2bbdf393d
institution Kabale University
issn 1469-5073
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Genetics Research
spelling doaj-art-7411e6cf8cc14739a79f04e2bbdf393d2025-02-03T06:47:37ZengWileyGenetics Research1469-50732023-01-01202310.1155/2023/2593199Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19Taravat Talebi0Tannaz Masoumi1Katayoun Heshmatzad2Mahshid Hesami3Majid Maleki4Samira Kalayinia5Rajaie Cardiovascular Medical and Research CenterRajaie Cardiovascular Medical and Research CenterRajaie Cardiovascular Medical and Research CenterRajaie Cardiovascular Medical and Research CenterCardiogenetic Research CenterCardiogenetic Research CenterBackground. Health and economies are both affected by the coronavirus disease-19 (COVID-19) global pandemic. Angiotensin-converting enzyme 2 (ACE2) is a polymorphic enzyme that is a part of the renin-angiotensin system, and it plays a crucial role in viral entry. Previous investigations and studies revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ACE2 have a considerable association. Recently, ACE2 variants have been described in human populations in association with cardiovascular and pulmonary conditions. In this study, genetic susceptibility to COVID-19 in different populations was investigated. Methods and Results. We evaluated the identified variants based on the predictive performance of 5 deleteriousness-scoring methods and the 2015 American College of Medical Genetics and Genomics (ACMG) guidelines. The results indicated 299 variants within the ACE2 gene. The variants were analyzed by different in-silico analysis tools to assess their functional effects. Ultimately, 5 more deleterious variants were found in the ACE2 gene. Conclusions. Collecting more information about the variations in binding affinity between SARS-CoV-2 and host-cell receptors due to ACE2 variants leads to progress in treatment strategies for COVID-19. The evidence accumulated in this study showed that ACE2 variants in different populations may be associated with the genetic susceptibility, symptoms, and outcome of SARS-CoV-2 infection.http://dx.doi.org/10.1155/2023/2593199
spellingShingle Taravat Talebi
Tannaz Masoumi
Katayoun Heshmatzad
Mahshid Hesami
Majid Maleki
Samira Kalayinia
Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19
Genetics Research
title Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19
title_full Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19
title_fullStr Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19
title_full_unstemmed Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19
title_short Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19
title_sort genetic variations in the human angiotensin convertingenzyme 2 and susceptibility to coronavirus disease 19
url http://dx.doi.org/10.1155/2023/2593199
work_keys_str_mv AT taravattalebi geneticvariationsinthehumanangiotensinconvertingenzyme2andsusceptibilitytocoronavirusdisease19
AT tannazmasoumi geneticvariationsinthehumanangiotensinconvertingenzyme2andsusceptibilitytocoronavirusdisease19
AT katayounheshmatzad geneticvariationsinthehumanangiotensinconvertingenzyme2andsusceptibilitytocoronavirusdisease19
AT mahshidhesami geneticvariationsinthehumanangiotensinconvertingenzyme2andsusceptibilitytocoronavirusdisease19
AT majidmaleki geneticvariationsinthehumanangiotensinconvertingenzyme2andsusceptibilitytocoronavirusdisease19
AT samirakalayinia geneticvariationsinthehumanangiotensinconvertingenzyme2andsusceptibilitytocoronavirusdisease19